DK1532139T3 - Totalsyntese af myriaporoner - Google Patents

Totalsyntese af myriaporoner

Info

Publication number
DK1532139T3
DK1532139T3 DK03771210T DK03771210T DK1532139T3 DK 1532139 T3 DK1532139 T3 DK 1532139T3 DK 03771210 T DK03771210 T DK 03771210T DK 03771210 T DK03771210 T DK 03771210T DK 1532139 T3 DK1532139 T3 DK 1532139T3
Authority
DK
Denmark
Prior art keywords
substituted
unsubstituted
group
aralkyl
aryl
Prior art date
Application number
DK03771210T
Other languages
English (en)
Inventor
Alvarez Marta Perez
Pozo Losada C Del
Solloso A Francesch
Marchante C Cuevas
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Application granted granted Critical
Publication of DK1532139T3 publication Critical patent/DK1532139T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
DK03771210T 2002-07-30 2003-07-30 Totalsyntese af myriaporoner DK1532139T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0217638.6A GB0217638D0 (en) 2002-07-30 2002-07-30 Total synthesis of myriaporones
PCT/GB2003/003327 WO2004011458A1 (en) 2002-07-30 2003-07-30 Total synthesis of myriaporones

Publications (1)

Publication Number Publication Date
DK1532139T3 true DK1532139T3 (da) 2007-10-15

Family

ID=9941374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03771210T DK1532139T3 (da) 2002-07-30 2003-07-30 Totalsyntese af myriaporoner

Country Status (20)

Country Link
US (1) US7521478B2 (da)
EP (1) EP1532139B1 (da)
JP (1) JP2006504659A (da)
KR (1) KR20050053599A (da)
CN (1) CN100390167C (da)
AT (1) ATE364603T1 (da)
AU (1) AU2003248984A1 (da)
CA (1) CA2494532A1 (da)
DE (1) DE60314426T2 (da)
DK (1) DK1532139T3 (da)
ES (1) ES2289337T3 (da)
GB (1) GB0217638D0 (da)
IL (1) IL166484A0 (da)
MX (1) MXPA05001176A (da)
NO (1) NO20051037L (da)
NZ (1) NZ537678A (da)
PT (1) PT1532139E (da)
RU (1) RU2328492C2 (da)
SI (1) SI1532139T1 (da)
WO (1) WO2004011458A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514708A (en) 1994-02-18 1996-05-07 Pharmamar, S.A. Cytotoxic metabolites from Myriapora truncata

Also Published As

Publication number Publication date
NZ537678A (en) 2006-11-30
KR20050053599A (ko) 2005-06-08
EP1532139A1 (en) 2005-05-25
RU2328492C2 (ru) 2008-07-10
EP1532139B1 (en) 2007-06-13
US20060084819A1 (en) 2006-04-20
IL166484A0 (en) 2006-01-15
US7521478B2 (en) 2009-04-21
GB0217638D0 (en) 2002-09-11
ATE364603T1 (de) 2007-07-15
WO2004011458A1 (en) 2004-02-05
ES2289337T3 (es) 2008-02-01
US20080269511A2 (en) 2008-10-30
RU2005105329A (ru) 2005-08-27
CA2494532A1 (en) 2004-02-05
AU2003248984A1 (en) 2004-02-16
DE60314426D1 (de) 2007-07-26
US20080103320A2 (en) 2008-05-01
SI1532139T1 (sl) 2007-10-31
JP2006504659A (ja) 2006-02-09
DE60314426T2 (de) 2008-02-14
NO20051037L (no) 2005-04-13
MXPA05001176A (es) 2005-09-12
CN1684956A (zh) 2005-10-19
PT1532139E (pt) 2007-09-20
CN100390167C (zh) 2008-05-28

Similar Documents

Publication Publication Date Title
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
NO20012617D0 (no) Kinolin- og kinzolinderivater
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
DK0535231T3 (da) Pyrimidinnucleosid-derivater
CY1113359T1 (el) Αντι-νεοπλασιακα παραγωγα του et-743
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
NO20051037L (no) Totalsyntese av myriaporoner
NO20040113L (no) Variolinderivater og deres anvendelse som antitumormidler
ATE552003T1 (de) Chinoxalinderivate
DE60116855D1 (de) Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität